
NIH should reconsider the Epigenomics Roadmap Initative
87
signers. Add your name now!

87
signers. Almost there! Add your voice!
87%

The undersigned urge the National Institutes of Health to reconsider the Epigenomics Roadmap Initiative. The initiative should be recast to consider a broader approach that supports fundamental valuable scientific discovery into cell-type programming at all levels and in a variety of biological systems.
Comment